Tagamet HB TV ad claiming "full prescription strength" enjoined by district court.
This article was originally published in The Tan Sheet
Executive Summary
TAGAMET HB TV AD CLAIMING Rx STRENGTH HEARTBURN TREATMENT PROHIBITED by federal court Judge Harold Baer in an April 24 bench decision. The N.Y. Southern District Court judge determined that the SmithKline Beecham ad claims -- that Tagamet HB is the only approved OTC H2 antagonist available in "full prescription strength" and that "nothing stops stomach acid faster" -- are "misleading" and possibly claims of "literal falsity."